SE430020B - Forfarande vid utvinning av den antihemofila faktorn (ahf) - Google Patents

Forfarande vid utvinning av den antihemofila faktorn (ahf)

Info

Publication number
SE430020B
SE430020B SE7307018A SE7307018A SE430020B SE 430020 B SE430020 B SE 430020B SE 7307018 A SE7307018 A SE 7307018A SE 7307018 A SE7307018 A SE 7307018A SE 430020 B SE430020 B SE 430020B
Authority
SE
Sweden
Prior art keywords
antihemophil
ahf
extraction
factor
procedure
Prior art date
Application number
SE7307018A
Other languages
English (en)
Inventor
L F Fekete
S L Holst
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of SE430020B publication Critical patent/SE430020B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
SE7307018A 1972-05-17 1973-05-17 Forfarande vid utvinning av den antihemofila faktorn (ahf) SE430020B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (1)

Publication Number Publication Date
SE430020B true SE430020B (sv) 1983-10-17

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7307018A SE430020B (sv) 1972-05-17 1973-05-17 Forfarande vid utvinning av den antihemofila faktorn (ahf)

Country Status (18)

Country Link
US (2) US3803115A (sv)
JP (1) JPS596845B2 (sv)
AT (1) AT344881B (sv)
AU (1) AU465351B2 (sv)
BE (1) BE799525A (sv)
CA (1) CA1007986A (sv)
CH (1) CH630804A5 (sv)
DE (1) DE2324717C3 (sv)
DK (1) DK136016B (sv)
ES (1) ES414823A1 (sv)
FR (1) FR2184898B1 (sv)
GB (1) GB1372515A (sv)
IL (1) IL42221A (sv)
IT (1) IT1061433B (sv)
NL (1) NL7306806A (sv)
NO (1) NO142381C (sv)
SE (1) SE430020B (sv)
ZA (1) ZA733138B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3684459D1 (de) * 1986-03-27 1992-04-23 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
CA2438223A1 (en) * 2001-02-07 2002-11-07 Shanbrom Technologies, Llc Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (sv) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
DE2324717B2 (de) 1980-01-03
IL42221A (en) 1977-04-29
DK136016B (da) 1977-08-01
CA1007986A (en) 1977-04-05
JPS596845B2 (ja) 1984-02-15
NL7306806A (sv) 1973-11-20
IT1061433B (it) 1983-02-28
FR2184898B1 (sv) 1976-11-05
USRE29698E (en) 1978-07-11
JPS4956695A (sv) 1974-06-01
AU465351B2 (en) 1975-09-25
AU5584973A (en) 1974-11-21
US3803115A (en) 1974-04-09
AT344881B (de) 1978-08-10
BE799525A (fr) 1973-08-31
ZA733138B (en) 1974-03-27
CH630804A5 (de) 1982-07-15
DE2324717A1 (de) 1973-12-13
DE2324717C3 (de) 1983-12-01
ES414823A1 (es) 1976-02-01
NO142381B (no) 1980-05-05
FR2184898A1 (sv) 1973-12-28
IL42221A0 (en) 1973-07-30
GB1372515A (en) 1974-10-30
DK136016C (sv) 1978-01-02
NO142381C (no) 1980-08-13
ATA433573A (de) 1975-04-15

Similar Documents

Publication Publication Date Title
SE430020B (sv) Forfarande vid utvinning av den antihemofila faktorn (ahf)
NO140556C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
FI54916B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
FI54700B (fi) Foerfarande foer framstaellning av hexametylendiamin
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
SE405488B (sv) Forfarande vid alkaliextraktion av cellulosahaltig massa
NO143220C (no) Fremgangsmaate for ekstraksjon av omegalaktamer
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
FI55207C (fi) Foerfarande foer framstaellning av 5-ledade omaettade isomera fosfindihalogenider
SE7505101L (sv) Forfarande for framstellning av emulgeringssystem.
SE388422B (sv) Forfarande for reduktion av theabin
CH501623A (de) Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
SE383825B (sv) Forfarande for extraktion av protein ur fron
FI54100B (fi) Foerfarande foer framstaellning av terapeutiskt vaerdefulla tricykliska foereningar
SE382227B (sv) Forfarande for separering av amylos.
SE403673B (sv) Forfarande for behandling av radioaktiva avgaser
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
FI53700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat
SE392900B (sv) Forfarande for framstellning av ftalazinderivat
SE382051B (sv) Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler
SE7609439L (sv) Forfarande for drivning av tunnlar
SE402599B (sv) Forfarande for fraktionering av amyloser
AT297216B (de) Verfahren zur Herstellung von therapeutischen Zubereitungen
RO64373A (ro) Procedeu pentru separarea izoprenului